PEDIATRIC TRANSPLANTATION, cilt.25, sa.5, 2021 (SCI-Expanded)
Background Post-transplant relapse has a dismal prognosis in children with acute leukemia undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Data on risk factors, treatment options, and outcomes are limited.